|
USP, EDQM, JP, IPC through Pharmacopeial Discussion Group on Nitrosamines
|
|
2
|
470
|
November 2, 2023
|
|
FDA - Pharmaceutical Quality Symposium
|
|
1
|
781
|
November 1, 2023
|
|
Useful interactive vedios on Nitrosamines Impuririties
|
|
2
|
372
|
November 1, 2023
|
|
Post any educational in-person event here!
|
|
2
|
761
|
November 9, 2023
|
|
Personal perspective on N-Nitrosamines and recent revision of guidelines
|
|
7
|
780
|
October 27, 2023
|
|
PAQ Experts Forum on Handling Nitrosamines & NDSRIs in Pharmaceuticals - to be held in Ahmedabad, Gujarat on 27th October, 2023
|
|
1
|
426
|
October 23, 2023
|
|
The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)
|
|
1
|
624
|
October 22, 2023
|
|
AAM GRx + Biosims 2023 -Event
|
|
5
|
480
|
October 16, 2023
|
|
Managing Nitrite Impurities: A Combined Supplier-Manufacturer View to Nitrosamine Risks
|
|
3
|
957
|
October 3, 2023
|
|
Uso de herramientas in-silico para Nitrosaminas
|
|
0
|
390
|
October 2, 2023
|
|
57th Congress of the European Societies of Toxicology (EUROTOX 2023)
|
|
0
|
521
|
September 18, 2023
|
|
Optimized method development strategies for the quantification of small and complex N-nitrosamines impurities
|
|
0
|
454
|
August 25, 2023
|
|
🗓 Nitrosamines Conversation Event w/ Dr. Raphael Nudelman
|
|
16
|
2461
|
August 17, 2023
|
|
Nitrosamines in EDQM 2023 Webinar Series
|
|
7
|
1076
|
August 10, 2023
|
|
Lhasa Japan Symposium
|
|
0
|
414
|
August 3, 2023
|
|
FDA Workshop: Mitigation Strategies for Nitrosamine Drug Substance Related Impurities
|
|
11
|
3187
|
July 27, 2023
|
|
HELM Mexico - Seminario Nitrosaminas
|
|
4
|
530
|
July 11, 2023
|
|
🕵️ Toxicology for non-toxicologist Training?
|
|
16
|
936
|
June 27, 2023
|
|
Mitagation Strategy for NDSRIs (FDA & CRCG) Workshop
|
|
10
|
2347
|
June 23, 2023
|
|
Nitrosamines: Current Regulatory Aspects and Analytical Challenges
|
|
0
|
714
|
June 23, 2023
|
|
Webinars (available on demand)
|
|
0
|
507
|
June 20, 2023
|
|
Fiscal Year (FY) 2023 Generic Drug Science and Research Initiatives Public Workshop May 11-12, 2023
|
|
3
|
601
|
June 15, 2023
|
|
FDA/HESI Research Roadmap Planning on Hazard and Risk Assessment of Nitrosamine Impurities in Drugs
|
|
18
|
3181
|
June 5, 2023
|
|
APEC - Safeguarding patients from Impurities in the drug supply chain - Nitrosamines
|
|
0
|
442
|
April 26, 2023
|
|
Generic Drugs Forum (GDF) 2023: Celebrating 10 Years of the GDF
|
|
1
|
530
|
April 16, 2023
|
|
7th Impurities: Genotoxic, Nitrosamine & Beyond Summit 15-16 March- Italy& Online
|
|
6
|
740
|
April 16, 2023
|
|
Analytical Testing of Nitrosamines in Drugs and Food
|
|
0
|
422
|
February 9, 2023
|
|
Joint FDA - Health Canada ICH Public Meeting Feb-24
|
|
0
|
522
|
January 10, 2023
|
|
FDA - Improving (Q)SAR review with Structure-Data Files
|
|
1
|
387
|
December 2, 2022
|
|
2 days seminar on nitrosamine and extractable & leachable
|
|
0
|
531
|
November 21, 2022
|